Cancer Drug Ruling Will Have Wide Impact
(AP) -- A decision expected Friday on federal approval for Genentech's Avastin cancer drug could have ramifications for all companies developing cancer medicines.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
» Next Article in Medicine & Health - Cancer: Hormone refractory prostate cancers more likely to spread to other organs

Rating: n/a
Bookmark
Save as PDF
Print
Email
Blog It
Stumble It!


PhysOrg Forum
Video
Editorials
Free Magazines
Free White Papers
Newsletter
Advanced Search
Goto Archive
Suggest a story idea
Send feedback